In Europe, more than 38% of the total direct costs in the dairy herd is necessary for treatment and prevention of subclinical mastitis (Erskine et al., 1993; Kartashova, 1995; . These heavy economic losses are further aggravated by the lack of reporting of subclinical infections as these cases are only often registered in countries with most intensive exploitation of animals, developed dairy cattle, and high level of mechanization and automation of production (Kartashova and Ivanov, 1993) .
To investigate the causes of subclinical mastitis, efforts have been made for a long time without any satisfactory success. Despite it is recognized by a wider community of researchers that microbial factors play crucial roles in the development of mastitis, subclinical mastitis has not yet been declared as an infectious disease in nosological profile (Avdeenko, 2009; Klimov and Slobodjanik, 2012) . It is suggested that disease is mainly contributed by environmental factors (associated with feeding and milking) (Bagmanov, 2011; Bradley, 2002) , or the illness is developed through polyetiologyque infection.
Recently, the market of pharmaceutical veterinary industry acquired popular products based on cephalosporins (Erskine et al., 2002) . Ceftiofur represents the third generation of cephalosporins, which is specifically synthesized for use in veterinary medicine (Wenz et al., 2005) . Tsefkinoma sulfate is a part of cephalosporin of the fourth generation, possesses a wide range of antibacterial action against majority of gram-positive and gram-negative bacteria (Avdeenko et al., 2016) .
The primary purpose of the study was to compare the therapeutic efficacy of ceftiofur and tsefkinoma sulfate for the treatment of subclinical mastitis during lactation.
MAtErIAlS And MEtHodS

animal experiment
The work was performed in 2011-2013 at the Department of Therapy, Obstetrics and Pharmacology, Saratov State Agrarian University, JSC Nita-Farm, and at farms of various patterns of ownership of Saratov region (Uchkhoz RGAU-ICCA them Timiryazev "Mummovskoe" Atkarsky District, JSC "Agri" Volga "Marxian district, K (F) X FE "AV Akimov "Bazarno-Karabulaksky District). A total of 781 milking cows of Simmental breed from the 7th to the 27th day after delivery, were used in the study. Studies were carried out under the guidelines of the European Convention for protection of animals.
During external examination of cows, attention was paid to hair condition, the shape of udder, and symmetry of quarters, skin colour, teat's size, and the sphincter of the teat canal. Using palpation the local temperature was defined, and the mammary gland consistency and presence of pain reaction was observed. Holding alternatively palpation of the right and left half mammary tissue by probing from the base to the top of teat, after that we determine the state of udder's lymph nodes, their size, consistency and pain reaction. Decanting to test the sphincter tonus of the teat canal and its permeability ends the clinical study. The quantity, homogeneity, colour, viscosity and appearance of milk secretion from each mammary quarter were examined and the presence of clots, flakes, blood and watery secretions were observed.
For the diagnosis of subclinical mastitis following test were performed: Ketotest (Intervet, the Netherlands), Masttest (Agrofarm, Russia), CMT -California mastitis test (Pfizer, USA). In addition, the somatic cell count was performed in the counting chamber with a grid and using Somatos mini.
According to the results of diagnostic test, two experimental groups were constituted. Group 1 consists of 389 cows and were treated with ceftiofur (ZAO "Nita-Farm" series -004 211 212) whereas Group 2 cows (n=392) were treated with tsefkinoma sulfate. Sick animals in each group were divided into two subgroups according to the frequency of the drugs used. Blood and mammary secretion sampling were performed before the application of the preparations, and after treatment at 24, 48, and 72 hours on the 5th day. Drugs were used through subcutaneous injection (SC) route in a therapeutic dose according to the instructions (Table 1) .
laboratory analyses
For haematological studies, an automatic haematology analyser (Abacus Junior Pse 90 Vet, Germany) and biochemical blood analyser (Chem Well combi Models 2902 and 2910, USA) were used. The number of somatic cells and the presence of antibiotics were determined in mammary secretions and BRT-test (AIM, Germany) was used for the determination of antibiotics.
Journal of Animal Health and Production
July 2016 | Volume 4 | Issue 3 | Page 97 
statistical analysis
Statistical analyses were performed using the standard Microsoft Excel 2000 and SPSS 10.0.5 for Windows and results were presented as mean± SEM. The significance level was considered when P < 0.05.
rESultS And dIScuSSIon
The therapeutic efficiency of the ceftiofur was appeared to be 90.0%, with a recovery average time of the udder function 2.93 ± 0.02 days. At the same time, the use of the drug based on tsefkinoma sulfate showed clinical benefit in 95.0% of cows, with an average recovery time of the udder function of 2.32 ± 0.03 days, from the beginning of treatment (Table 2 ). These data suggest high therapeutic efficiency of the drugs administered to cows with subclinical mastitis (90.0-100.0%) with a sufficiently good recovery timing of 2.64 ± 0.03-3.23 ± 0.02 days, and no disease recurrence ( Table 2 ).
The absence of antibiotics in milk facilitates the use of these drugs in dairy herd. Drugs based on ceftiofur can be used without restriction in lactating animals, which is confirmed by special studies conducted in Russia (Klimov and Slobodjanik, 2012) . However, there was apprehension due to changes of the tissues caused by mastitis, ceftiofur can be found in the produced milk in quantities that exceed the acceptable permitted limit. Therefore, investigation on the presence of antimicrobials in milk is imperative.
Results of antibacterial substances found in mammary secretions have been summarized in Table 3 . Significant changes in the content of immunoglobulin class G and M, and an increase in antibody titre, a decrease of phagocytic index was observed which indicates the beginning of antibody production after 5 days ).
After the treatment of subclinical mastitis with the drug based on ceftiofur, on the 5th day from the beginning of treatment in comparison to the before treatment, there was a significant decrease in the udder somatic cells secretion by 14.78 times. The concentration of lactoferrin (LF) was decreased by 3.54 times, lactoperoxidase (LPO) by 1.86 times (Marek et al., 2011) , and the activity muramidase (M3) has increased by 1.67 times (Riaz et al., 2012) .
High blood levels of white blood cells due to the increase in neutrophil forms; stab by 63.6% and 25.4% segmented ones was recorded. At the same time, the number of lymphocytes was lowered by 6.4% and monocytes by 46.7%. The development of neutropenia was redistributed from the bloodstream into the mammary gland at a significant number ).
The number of erythrocytes reduced by 1.23 times. In 29.4% of animals, erythrocyte sedimentation rate (ESR) was within normal limits (moderate in 25.1%, and the average in 30.2%). Thrombocytes contents in the blood were reduced by 26.6-39.6% and hemoglobin by 13.9% (p <0.05) ( Table 4) .
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Thrombocytes (10 9 /l) 627.5 ± 12.7 544.75 ± 37.9 638.5 ± 17.5 564.65 ± 72.5
Hemoglobin (g / l) 95.0 ± 3.4 120.3 ± 2.6 97.0 ± 4.5 126.4 ± 9.9 ESR (mm / hr) 3.27 ± 0.35 2.64 ± 0.32 3.07 ± 0.31 2.76 ± 0.21 C3 17.6 ± 3.1 18.4 ± 2.0 1.6 ± 2.0 18.6 ± 1.7 C4 24.0 ± 3.6 33.3 ± 1.3 28.4 ± 2.0 42.5 ± 2.6
Phagocytic index (%) 1.02 ± 0.07 7.0 ± 0.1 1.00 ± 0.04 5.6 ± 0.4 Table 4 also shows the total protein level in blood at the beginning of lactation was increased to 10.2-18.1% reflecting the metabolic processes intensity after calving. In cows with subclinical mastitis, a decreased content of γ-globulins was observed (38.1%), and increased proportion of α-and β-globulins was noticed. Decrease in blood γ-globulin occurred due to active transport into the mammary gland. This reduction of immunoglobulin G by 26.3% was noticed due to the decrease of antigen binding activity of the formed immunoglobulin. This is indicated by the low concentration (11.9 ± 1.13 EU) of the circulating immune complexes (CIC, C3) and their small sizes (C4: C3 = 2.10-2.16) (Matei et al., 2010) . Strengthening the antigen binding activity of the humoral factors of subclinical mastitis in cows in early lactation due to the presence in the blood of a heterogeneous by specific population of autoantibodies generated during involution process of genital organs after calving . Overall, both therapeutic agents were found more than 90% effective for the treatment of subclinical mastitis in cows (Table 5 ).
The results showed that after single and subsequent administration of the drug based on ceftiofur in the milk of cows with subclinical mastitis, antibiotics were not detected in any of the samples (Table 6 ). After administration of the drug on the basis of tsefkinoma sulfate, antibiotic was discovered in all milk samples, which corresponded to the limitations specified in the instructions (Avdeenko, 2009 ).
During haematological studies, it was revealed that a subclinical mastitis was observed with leukocytosis in 29.5 % of cows from 15 to 20 thousands / mm3, while 51.5 % of the animals -from 20.6 to 43.9 thousands / mm3. The calculation of economic losses from lower milk production was carried out according to the instructions of the Veterinary Department of Agriculture of the Russian Federation (2010) and results are shown in Table 7 .
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Cost-effectiveness of the treatment of subclinical mastitis with the drug based on ceftiofur estimates 0.17 USD, and the preparation based on tsefkinoma sulfate costs 0.11 USD.
concluSIonS
The analysis of the data showed that after treatment with ceftiofur and tsefkinoma sulfate, a decrease in somatic cell number, lactoperoxidase, lactoferrin occurred. When applying the drug thrice with ceftiofur (dose -1.0 ml/50 kg live body weight, 1 time in 24 h) and tsefkinoma sulfate (dose -2.0 ml/kg of 50 live body weight, 1 time in 24 h) therapeutic efficiency reached 100.0% with an average recovery duration of 2.64 ± 0. 03-3.23 ± 0.02 days, with total absence of disease recurrence. The drug based on ceftiofur unlike tsefkinoma sulfate was not found by the BRT-test in milk and thus it can be recommended for use in dairy herd without any restrictions.
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